ARTICLE | Clinical News
Tetmodis tetrabenazine regulatory update
July 13, 2015 7:00 AM UTC
AOP Orphan submitted a regulatory application for Tetmodis tetrabenazine under the EU’s decentralized procedure to treat tardive dyskinesia. The U.K. is the reference member state. The small molecule ...